Document Detail


A comparison of medical management with misoprostol and surgical management for early pregnancy failure.
MedLine Citation:
PMID:  16120856     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Misoprostol is increasingly used to treat women who have a failed pregnancy in the first trimester. We assessed the efficacy, safety, and acceptability of this treatment in a large, randomized trial. METHODS: A total of 652 women with a first-trimester pregnancy failure (anembryonic gestation, embryonic or fetal death, or incomplete or inevitable spontaneous abortion) were randomly assigned to receive 800 microg of misoprostol vaginally or to undergo vacuum aspiration (standard of care) in a 3:1 ratio. The misoprostol group received treatment on day 1, a second dose on day 3 if expulsion was incomplete, and vacuum aspiration on day 8 if expulsion was still incomplete. Surgical treatment (for the misoprostol group) or repeated aspiration (for the vacuum-aspiration group) within 30 days after the initial treatment constituted treatment failure. RESULTS: Of the 491 women assigned to receive misoprostol, 71 percent had complete expulsion by day 3 and 84 percent by day 8 (95 percent confidence interval, 81 to 87 percent). Treatment failed in 16 percent of the misoprostol group and 3 percent of the surgical group (absolute difference, 12 percent; 95 percent confidence interval, 9 to 16 percent) by day 30. Hemorrhage or endometritis requiring hospitalization was rare (1 percent or less in each group), with no significant differences between the groups. In the misoprostol group, 78 percent of the women stated that they would use misoprostol again if the need arose and 83 percent stated that they would recommend it to others. CONCLUSIONS: Treatment of early pregnancy failure with 800 microg of misoprostol vaginally is a safe and acceptable approach, with a success rate of approximately 84 percent.
Authors:
Jun Zhang; Jerry M Gilles; Kurt Barnhart; Mitchell D Creinin; Carolyn Westhoff; Margaret M Frederick;
Related Documents :
1258906 - Outpatient postconceptional fertility control with vaginally administered 15(s) 15-meth...
1927296 - The use of antiprogestin (ru 486) for termination of second trimester pregnancy.
6232806 - Pregnancies after terminal microsurgical tuboplasties with early laparoscopic control o...
12326936 - Prostaglandin and the corpus luteum of pregnancy.
12818976 - Spinal anesthesia for cesarean delivery in a woman with a surgically corrected type i a...
9315286 - Effect of malathion on kinetic parameters of acetylcholinesterase (ec 3.1.1.7) in vitro.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The New England journal of medicine     Volume:  353     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-25     Completed Date:  2005-08-30     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  761-9     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2005 Massachusetts Medical Society.
Affiliation:
Epidemiology Branch, National Institute of Child Health and Human Development, Bethesda, Md 20892, USA. zhangj@mail.nih.gov.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / adverse effects,  therapeutic use*
Abortion, Spontaneous / drug therapy*,  surgery*
Adult
Endometritis / etiology
Female
Fetal Death
Hemorrhage / etiology
Humans
Misoprostol / adverse effects,  therapeutic use*
Postoperative Complications
Pregnancy
Pregnancy Trimester, First
Vacuum Curettage
Grant Support
ID/Acronym/Agency:
N01-HD-1-3321/HD/NICHD NIH HHS; N01-HD-3322/HD/NICHD NIH HHS; N01-HD-3323/HD/NICHD NIH HHS; N01-HD-3324/HD/NICHD NIH HHS; N01-HD-3325/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol
Comments/Corrections
Comment In:
N Engl J Med. 2005 Aug 25;353(8):834-6   [PMID:  16120864 ]
N Engl J Med. 2005 Dec 1;353(22):2403-4; author reply 2403-4   [PMID:  16319392 ]
N Engl J Med. 2005 Dec 1;353(22):2403-4; author reply 2403-4   [PMID:  16320450 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Brain tumor-associated dementia.
Next Document:  Costimulation blockade with belatacept in renal transplantation.